BioSpace News Archive

ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, recently announced the appointment of Dr. Sridhar Narayan as Vice President responsible for the global Medicinal Chemistry team.

Telegraph Hill Partners (THP), a leading venture capital and growth equity firm dedicated exclusively to life science and healthcare investing, today announced the addition of Raymond Falci to its investment team.

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx” or “Company”) is reporting today that its U.S. joint venture (JV) partner and licensee, HLB Therapeutics (HLBT), has announced that it submitted a request for the Special Protocol Assessment (SPA) to the U.S. FDA for an in-depth discussion and assessment of the clinical protocol for a fourth phase 3 clinical trial (ARISE-4) for the treatment of dry eye disease.

Adagio Medical, Inc. announced its first pulsed field cryoablation (PFCA) procedure performed using the Adagio CryoPulse™ catheter system as part of the PARALELL (Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibriLlation) clinical trial, NCT #05408754.

PharmaJet® announced they received a multi-year, $1.5 million grant from the United States Agency for International Development, to evaluate the impact of intradermal vaccine administration using their Tropis® Needle-free Injection System.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended September 30, 2022, after the close of market on Thursday, October 27, 2022.

Naveris, Inc., a leader in molecular diagnostics for viral cancers, today announced that the company and the principle investigator at Mayo Clinic will present its award-winning abstract at the American Society for Radiation Oncology (ASTRO) Annual Meeting held October 23-26, 2022.

Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, has been named a finalist in the 2022 Fierce Healthcare Innovation Awards for its Cardea SOLO™ ECG System.

Xoran Technologies presented TRON™—the latest innovative addition to Xoran’s suite of truly mobile CT systems—at a series of high-profile neurosurgery, spine, and critical care events this month.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will report its third quarter financial results on Thursday, November 3, 2022.